Bio-Techne (TECH) Equity Average (2010 - 2026)

Bio-Techne has reported Equity Average for 17 years, with the latest figure at $2.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Equity Average changed 0.01% year-over-year to $2.0 billion; the trailing twelve-month figure through Mar 2026 stood at $2.0 billion (changed 0.01% YoY), and the FY2025 full-year result was $2.0 billion, down 1.18% from the prior year.
• Equity Average for Q1 2026 stood at $2.0 billion, up from $2.0 billion in the prior quarter.
• The five-year high for Equity Average was $2.1 billion in Q4 2024, with the low at $1.7 billion in Q2 2022.
• Average Equity Average over 5 years is $1.9 billion, with a median of $2.0 billion recorded in 2023.
• Year-over-year, Equity Average gained 14.83% in 2023 and retreated 7.67% in 2025.
• Tracing TECH's Equity Average over 5 years: stood at $1.8 billion in 2022, then rose by 10.7% to $2.0 billion in 2023, then rose by 6.46% to $2.1 billion in 2024, then slipped by 5.7% to $2.0 billion in 2025, then increased by 3.0% to $2.0 billion in 2026.
• The last three Equity Average figures came in at $2.0 billion (Q1 2026), $2.0 billion (Q4 2025), and $1.9 billion (Q3 2025), per Business Quant data.

Peer Comparison